All stories tagged :

Pr Newswire

Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and...

admin
Pr Newswire

Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)

admin
Pr Newswire

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of...

admin
Pr Newswire

Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement

admin
Pr Newswire

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND...

admin
Pr Newswire

China firms up confidence of success, strives to transform all positive...

admin
Pr Newswire

GTC FX Celebrates 12 years of Excellence with the Golden Falcon...

admin
Pr Newswire

Bybit Upgrades its Trading Bot to Support Smarter Automatic Trading Strategies

admin
Pr Newswire

Tokyo Lifestyle Co., Ltd. Reports First Six Months of Fiscal Year...

admin
Pr Newswire

AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued...

admin
Pr Newswire

NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with...

admin

Featured

Pr Newswire

Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and...

admin
Pr Newswire

Luma Nutrition Magnesium Glycinate Surpasses 10,000 Monthly Sales on Amazon

admin
Pr Newswire

Aerolib Healthcare Solutions Unveils Aerolib AI: The Ultimate Appeals Machine

admin
Pr Newswire

Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International...

admin
admin

Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and...

ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced the appointments of Veet Misra, Ph.D., as the Company’s Chief...